|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| A61K 31/437 | |||
| A61P 35/00 |
| (11) | Number of the document | 3033343 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14792587.9 |
| Date of filing the European patent application | 2014-08-14 | |
| (97) | Date of publication of the European application | 2016-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/063916 |
| Date | 2014-08-14 |
| (87) | Number | WO 2015/022662 |
| Date | 2015-02-19 |
| (30) | Number | Date | Country code |
| DE24182013 | 2013-08-14 | IN | |
| DE16862014 | 2014-06-24 | IN |
| (72) |
BOCK, Mark Gary, US
MOEBITZ, Henrik, CH
PANIGRAHI, Sunil Kumar, IN
PODDUTOORI, Ramulu, IN
SAMAJDAR, Susanta, IN
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK |
| COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK |